Compare DNN & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DNN | HTFL |
|---|---|---|
| Founded | 1954 | 2007 |
| Country | Canada | United States |
| Employees | N/A | 843 |
| Industry | Other Metals and Minerals | |
| Sector | Basic Materials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.5B |
| IPO Year | 1998 | N/A |
| Metric | DNN | HTFL |
|---|---|---|
| Price | $3.06 | $33.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $6.50 | ★ $38.20 |
| AVG Volume (30 Days) | ★ 22.0M | 1.1M |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $403.36 | $27.66 |
| Revenue Next Year | N/A | $23.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.71 | $20.13 |
| 52 Week High | $4.43 | $41.22 |
| Indicator | DNN | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 42.07 | 63.86 |
| Support Level | $2.56 | $32.09 |
| Resistance Level | $3.36 | $36.68 |
| Average True Range (ATR) | 0.19 | 2.02 |
| MACD | -0.03 | 0.24 |
| Stochastic Oscillator | 32.39 | 99.45 |
Denison Mines Corp is engaged in uranium mining-related activities, including the acquisition, exploration, development, and mining of uranium-bearing properties, as well as the processing, sale, and investment in uranium. The company's key properties include Wheeler River, Waterbury Lake, McClean Lake, Midwest, and others. It operates through two segments: the Mining segment and the Corporate and Other segment. The majority of the company's revenue is generated from the Mining segment, which includes activities related to exploration, evaluation, and development, mining, milling (including toll milling), and the sale of mineral concentrates.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.